Vanda Pharmaceuticals
VNDA
VNDA
101 hedge funds and large institutions have $428M invested in Vanda Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
101
Holders Change
-9
Holders Change %
-8.18%
% of All Funds
2.93%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
7
Increased
38
Reduced
34
Closed
16
Calls
$10.5M
Puts
$13.7M
Net Calls
-$3.14M
Net Calls Change
-$36.4M
Top Buyers
| 1 |
DM
1
Deerfield Management
New York
|
$22.5M |
| 2 |
JGC
2
J. Goldman & Co
New York
|
$10.1M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$42.6M |
| 4 |
4
Millennium Management
New York
|
$6.43M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$18.8M |
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$0 |
| 2 |
CCM
2
Cupps Capital Management
Chicago,
Illinois
|
$0 |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$12.7M |
| 4 |
4
D.E. Shaw & Co
New York
|
$431K |
| 5 |
SCA
5
Signpost Capital Advisors
New York
|
$16.3M |
